Loomis, Sayles & Company
MED icon

Loomis, Sayles & Company’s Medifast MED Stock Holding History

Loomis, Sayles & Company’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-79,488
Closed -$8.24M – 752
2019
Q3 		$8.24M Buy
+79,488
New +$8.54M 0.02% 373
2017
Q4 		– Sell
-70
Closed -$4K – 904
2017
Q3 		$4K Hold
70
– – ﹤0.01% 857
2017
Q2 		$3K Hold
70
– – ﹤0.01% 892
2017
Q1 		$3K Hold
70
– – ﹤0.01% 908
2016
Q4 		$3K Hold
70
– – ﹤0.01% 954
2016
Q3 		$3K Hold
70
– – ﹤0.01% 940
2016
Q2 		$2K Sell
70
-179
-72% -$5.78K ﹤0.01% 947
2016
Q1 		$8K Sell
249
-341
-58% -$9.97K ﹤0.01% 866
2015
Q4 		$18K Sell
590
-142
-19% -$4.23K ﹤0.01% 802
2015
Q3 		$20K Sell
732
-365
-33% -$10.6K ﹤0.01% 850
2015
Q2 		$35K Buy
+1,097
New +$34.8K ﹤0.01% 727

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Loomis, Sayles & Company's MED Position: Q4 2019 in Review

Loomis, Sayles & Company sold out of Medifast (MED) in Q4 2019, closing a stake of 79,488 shares — an estimated $8.24M sold.

Loomis, Sayles & Company first reported a position in MED in Q2 2015 and held it in 11 quarters. The position peaked at $8.24M in Q3 2019. 219 funds tracked by Wall St. Rank hold MED as of Q4 2019.

  • Loomis, Sayles & Company reported no remaining Medifast position as of Q4 2019 after selling out during the quarter.
  • Loomis, Sayles & Company sold 79,488 Medifast shares in Q4 2019, an estimated $8.24M.
  • Loomis, Sayles & Company first reported a position in Medifast in Q2 2015 and held it in 11 quarters.
  • Loomis, Sayles & Company's Medifast position peaked at $8.24M in Q3 2019.
  • 219 funds tracked by Wall St. Rank held Medifast as of Q4 2019.

Based on Loomis, Sayles & Company's 13F filing for Q4 2019, filed 14 Feb 2020.